1.河北医科大学药学院,石家庄 050017
2.河北省 人民医院药学部,石家庄 050051
3.河北省临床药学重点实验室,石家庄 050051
Received:15 August 2025,
Revised:2026-01-22,
Accepted:23 January 2026,
Published:28 February 2026
移动端阅览
张俐婷,杨浩天,于思奇,等.ICU常用16种静脉用抗菌药物配伍稳定性研究[J].中国药房,2026,37(04):468-475.
ZHANG Liting,YANG Haotian,YU Siqi,et al.Study on the compatibility stability of 16 commonly used intravenous antibiotics in ICU[J].ZHONGGUO YAOFANG,2026,37(04):468-475.
张俐婷,杨浩天,于思奇,等.ICU常用16种静脉用抗菌药物配伍稳定性研究[J].中国药房,2026,37(04):468-475. DOI: 10.6039/j.issn.1001-0408.2026.04.10.
ZHANG Liting,YANG Haotian,YU Siqi,et al.Study on the compatibility stability of 16 commonly used intravenous antibiotics in ICU[J].ZHONGGUO YAOFANG,2026,37(04):468-475. DOI: 10.6039/j.issn.1001-0408.2026.04.10.
目的
2
系统分析重症监护病房(ICU)常用抗菌药物的配伍稳定性,为临床合理用药提供循证依据。
方法
2
收集河北省人民医院合理用药监测系统中2024年1-12月的ICU用药数据,向河北省内重症医学及药学专家进行咨询,结合药品说明书、 Micromedex、Trissel’s Injectable Drug Handbook、PubMed等数据库中的药物相容性检索结果,筛选ICU常用抗菌药物及其他静脉药物,对药物组合的理化稳定性进行分析;同时,采用Cytoscape 3.10.2软件构建药物相容性网络互作图,对高风险药物进行识别。
结果与结论
2
本研究共收集到ICU常用的16种抗菌药物及65种静脉药物的904个两两配伍的药物组合,其中549个组合(60.7%)相容,88个组合(9.7%)不相容,82个组合(9.1%)证据矛盾,185个组合(20.5%)证据缺失。不相容性风险较高的药物主要包括注射用两性霉素B、注射用头孢他啶、注射用亚胺培南西司他丁钠、注射用头孢曲松钠、注射用盐酸万古霉素等。药物间的不相容性风险因素主要包括药物浓度、温度、混合速度、pH及药物化学结构等。临床使用时,应依据具体药物的相容性数据,合理选择药物与溶媒,并加强对药物相容性的研究与监测。
OBJECTIVE
2
To systematically analyze the compatibility stability of commonly used intravenous antibiotics in the intensive care unit (ICU), and to provide evidence-based support for rational clinical drug use.
METHODS
2
Medication data from the ICU of Hebei General Hospital between January and December 2024 were extracted from the Prescription Automatic Screening System. Commonly used intravenous antibiotics and other intravenous drugs in the ICU were selected through consultations with critical care and pharmacy experts in Hebei province, drug package inserts and compatibility information retrieved from Micromedex, Trissel’s Injectable Drug Handbook and PubMed. The physicochemical stability of drug combinations was analyzed. In addition, Cytoscape 3.10.2 software was used to construct a drug compatibility network for identifying high-risk drugs.
RESULTS &CONCLUSIONS
2
A total of 904 pairwise drug combinations involving 16 antibacterial agents and 65 intravenous drugs were collected. Among them, 549 combinations (60.7%) were compatible, 88 combinations (9.7%) were incompatible, 82 combinations (9.1%) had conflicting evidence, and 185 combinations (20.5%) lacked valid data support. High-risk combination drugs primarily involved Amphotericin B for injection, Ceftazidime for injection, Imipenem-cilastatin for injection, Ceftriaxone sodium for injection, Vancomycin hydrochloride for injection, etc. The main risk factors for drug-drug incompatibility included drug concentration, temperature, mixing rate, pH, and chemical structure. In clinical practice, drugs and diluents should be selected rationally based on specific compatibility data, and research and monitoring of drug compatibility should be further strengthened.
SEYMOUR C W , GESTEN F , PRESCOTT H C , et al . Time to treatment and mortality during mandated emergency care for sepsis [J ] . N Engl J Med , 2017 , 376 ( 23 ): 2235 - 2244 .
DETTLAFF K , ANGLART G , GRUSZCZYŃSKA A , et al . Compatibility studies of selected multichamber bag parenteral nutrition with fluconazole [J ] . Nutrition , 2024 , 123 : 112417 .
LIU Y G , LIAO M H , SANG X Q , et al . A case of precipitate in intravenous line when general anesthesia implemented with remimazolam [J ] . Heliyon , 2022 , 8 ( 12 ): e12491 .
BRADLEY J S , WASSEL R T , LEE L , et al . Intravenous ceftriaxone and calcium in the neonate:assessing the risk for cardiopulmonary adverse events [J ] . Pediatrics , 2009 , 123 ( 4 ): e609 - e613 .
BARG N L , SUPENA R B , FEKETY R . Persistent staphylococcal bacteremia in an intravenous drug abuser [J ] . Antimicrob Agents Chemother , 1986 , 29 ( 2 ): 209 - 211 .
MARSILIO N R , DA SILVA D , BUENO D . Drug incompatibilities in the adult intensive care unit of a university hospital [J ] . Rev Bras Ter Intensiva , 2016 , 28 ( 2 ): 147 - 153 .
LESSARD J J , CARON E , SCHÉRER H , et al . Compa-tibility of Y-site injection of meropenem trihydrate with 101 other injectable drugs [J ] . Hosp Pharm , 2020 , 55 ( 5 ): 332 - 337 .
Truven Health Analytics . Micromedex [DB/OL ] . [ 2025-02-15 ] . https://www.micromedexsolutions.com https://www.micromedexsolutions.com .
GIMÉNEZ-GINER S , LLOPIS-ALEMANY A , PORTA-OLTRA B , et al . Chemical stability and physical compa-tibility of meropenem in admixtures for continuous and extended intravenous infusions [J ] . Enferm Infecc Microbiol Clin(Engl Ed) , 2023 , 41 ( 10 ): 612 - 616 .
KEEL R A , SUTHERLAND C A , CRANDON J L , et al . Stability of doripenem,imipenem and meropenem at ele-vated room temperatures [J ] . Int J Antimicrob Agents , 2011 , 37 ( 2 ): 184 - 185 .
MEHTA S , ARMSTRONG B K , KIM S J , et al . Long-term potency,sterility,and stability of vancomycin,ceftazidime,and moxifloxacin for treatment of bacterial endophthalmitis [J ] . Retina , 2011 , 31 ( 7 ): 1316 - 1322 .
WALKER S E , IAZZETTA J , LAW S , et al . Stability of commonly used antibiotic solutions in an elastomeric infusion device [J ] . Can J Hosp Pharm , 2010 , 63 ( 3 ): 212 - 224 .
DONNELLY R F . Stability of aseptically prepared tazocin solutions in polyvinyl chloride bags [J ] . Can J Hosp Pharm , 2009 , 62 ( 3 ): 226 - 231 .
SAHRAOUI L , CHIADMI F , SCHLATTER J , et al . Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections [J ] . Am J Health Syst Pharm , 2006 , 63 ( 15 ): 1423 - 1426 .
HE J , FIGUEROA D A , LIM T P , et al . Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 degrees C [J ] . Am J Health Syst Pharm , 2010 , 67 ( 14 ): 1191 - 1194 .
LIM T P , HEE D K , LEE W , et al . Physicochemical stabi-lity study of polymyxin B in various infusion solutions for administration to critically ill patients [J ] . Ann Pharmacother , 2016 , 50 ( 9 ): 790 - 792 .
TSIOURIS M , ULMER M , YURCHO J F , et al . Stability and compatibility of reconstituted caspofungin in select elastomeric infusion devices [J ] . Int J Pharm Compd , 2010 , 14 ( 5 ): 436 - 439 .
CURTI C , SOUAB H K , LAMY E , et al . Stability studies of antipyocyanic beta-lactam antibiotics used in continuous infusion [J ] . Pharmazie , 2019 , 74 ( 6 ): 357 - 362 .
SORNSUVIT C , WIENTONG P , UITRAKUL S , et al . Influence of concentration and temperature on stability of imipenem focused on solutions for extended infusion [J ] . Dose Response , 2021 , 19 ( 4 ): 15593258211059325 .
郑晨 , 王钰 , 何晓静 , 等 . 对头孢他啶注射液稳定性的影响因素研究 [J ] . 中国临床药理学杂志 , 2017 , 33 ( 23 ): 2443 - 2445 .
CAVASSIN F B , BAÚ-CARNEIRO J L , VILAS-BOAS R R , et al . Sixty years of amphotericin B:an overview of the main antifungal agent used to treat invasive fungal infections [J ] . Infect Dis Ther , 2021 , 10 ( 1 ): 115 - 147 .
吕薛 , 胡立宏 . 两性霉素B的结构修饰研究进展 [J ] . 药学研究 , 2016 , 35 ( 11 ): 621 - 627 .
RAVERDY V , AMPE E , HECQ J D , et al . Stability and compatibility of vancomycin for administration by continuous infusion [J ] . J Antimicrob Chemother , 2013 , 68 ( 5 ): 1179 - 1182 .
MEYER K , SANTAROSSA M , DANZIGER L H , et al . Compatibility of ceftazidime-avibactam,ceftolozane-tazobactam,and piperacillin-tazobactam with vancomycin in dextrose 5% in water [J ] . Hosp Pharm , 2017 , 52 ( 3 ): 221 - 228 .
LEUNG E , VENKATESAN N , LY S C , et al . Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions [J ] . Am J Health Syst Pharm , 2013 , 70 ( 13 ): 1163 - 1166 .
CONDIE C K , TYLER L S , BARKER B , et al . Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery [J ] . Am J Health Syst Pharm , 2008 , 65 ( 5 ): 454 - 457 .
O’DONNELL J N , VENKATESAN N , MANEK M , et al . Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations [J ] . Am J Health Syst Pharm , 2016 , 73 ( 4 ): 241 - 246 .
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
